
Last updated: about 1 month ago
BioMarin Pharmaceutical Inc. 8-K Report: Key Updates & Insights
Explore BioMarin Pharmaceutical Inc.'s 8-K report from February 20, 2025, detailing critical corporate events and financial disclosures for investors.
Explore BioMarin Pharmaceutical Inc.'s 8-K report from February 20, 2025, detailing critical corporate events and financial disclosures for investors.
Explore BioMarin Pharmaceutical Inc.'s 8-K filing from February 19, 2025, detailing significant corporate events. Discover implications for stock performance and company operations.